Close
Nordic 9Nordic 9

AdBio partners (investor - Venture Capital)

France adbio.partners
See something wrong or missing? Let us know
Offices:Paris

AdBio partners is a venture capital fund supported in particular by the National Seed-Fund from France, with a focus on early-stage startups in life sciences in Europe.

Average round investment:30.29M USD
Average number per year:2.1
Distribution: 2025 (3)2024 (2)2023 (6)2022 (1)2021 (1) See the entire list
Portfolio companies: Switzerland EvlaBioBelgium Augustine TherapeuticsDenmark Cephagenix See the entire list
Mostly invests in: Belgium Belgium (6) Biotech (15)
See the entire list

Showing 3 of 15 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

AdBio partners mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to AdBio partners

Name Criteria
France Creadev
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium Vives Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium VIB
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, Denmark
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France, Denmark
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Air Street Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
United States Paladin Capital Group
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Spain
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
France Turenne Capital Partenaires
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United States MassMutual Ventures
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Spain
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
United States +ND Capital
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top